The laboratory risk assessment and control testing 2019 novel coronavirus in biosafety class II laboratories
10.3760/cma.j.issn.1009-9158.2010.0007
- VernacularTitle: 生物安全Ⅱ级实验室开展新型冠状病毒感染患者实验检测的风险评估与防控
- Author:
Wenhao HUA
1
;
Linjun SHENG
2
;
Lihong SONG
3
;
Qingtao WANG
4
Author Information
1. Clinical Laboratory, Peking University People’s Hospital, Beijing100044, China
2. Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing100015, China
3. Infection Prevention and Control Department, Beijing Friendship Hospital, Capital Medical University , Beijing100050, China
4. Clinical Laboratory ,Beijing Chao-Yang Hospital, Capital Medical University, Beijing100020, China
- Publication Type:Journal Article
- Keywords:
Coronavirus;
Coronavirus infections;
Risk assessment;
Containment of Biohazards
- From:
Chinese Journal of Laboratory Medicine
2020;43(0):E007-E007
- CountryChina
- Language:Chinese
-
Abstract:
The outbreak of 2019 Novel Coronavirus (2019-nCoV) has spread from Wuhan to the whole country. After the Spring Festival, workers will return to workplace and students will return to school. There is an increasing risk of 2019-nCoV cases being imported into provinces and cities. In order to promote the prevention and control of 2019-nCoV infection, reduce the risk of transmission in medical institutions, and ensure medical quality and medical safety, it is necessary to carry out the detection test of 2019-nCoV in biosafety class II laboratory. In order to achieve the goal of zero infection of the laboratory personnel, different preventive measures should be taken to assess the risk of the experimental activities.
